Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: Clinical implication of early limited use of infliximab

Modern Rheumatology

Volumn 17, Issue 6, 2007, Pages 500-506

  Mori, Shunsuke ^a   Koga, Yukinori ^a   Imamura, Fumiya ^a   Cho, Isamu ^a   Sugimoto, Mineharu ^a  

^a Kumamoto Saishunsou National Hospital   (Japan)

Author keywords

Amyloidosis; CT guided lung biopsy; Infliximab; Methotrexate; Rheumatoid arthritis; Sj gren's syndrome

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GALLIUM CITRATE GA 67; GOLD; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR; ISONIAZID; LA ANTIBODY; M PROTEIN; METHOTREXATE; PREDNISOLONE; RHEUMATOID FACTOR; RO ANTIBODY; SERUM AMYLOID A; STROMELYSIN;

ADULT; AMYLOIDOSIS; ARTHRALGIA; ARTICLE; BONE EROSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG WITHDRAWAL; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HAND RADIOGRAPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOCHEMISTRY; JOINT SWELLING; LIP BIOPSY; LUNG CALCIFICATION; LUNG NODULE; LUNG TUBERCULOSIS; LYMPHOCYTIC INFILTRATION; MONOTHERAPY; MORNING STIFFNESS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SCHIRMER TEST; SCORING SYSTEM; SJOEGREN SYNDROME; SYNOVITIS; THORAX RADIOGRAPHY; TREATMENT REFUSAL; TUBERCULIN TEST; WHOLE BODY SCINTISCANNING; XEROSTOMIA;

AMYLOID; AMYLOIDOSIS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG DISEASES; METHOTREXATE; MIDDLE AGED; REMISSION INDUCTION; SJOGREN'S SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; WITHHOLDING TREATMENT;

EID: 37449020678     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0617-4     Document Type: Article

References (32)

1. D van der Heijide 1995 Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34 Suppl 2 74-8
2. VP Nell KP Machold G Eberl TA Stamm M Uffmann JS Smolen 2004 Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43 906-14 10.1093/rheumatology/keh199 1:CAS:528:DC%2BD2cXlt1Wltr8%3D
3. S Pavy A Constantin T Pham L Gossec JF Maillefert A Cantagrel 2006 Methotrexate therapy for rheumatoid arthritis: Clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 73 388-95 16626993 10.1016/j.jbspin.2006.01.007 1:CAS:528:DC%2BD28XptVKjtL0%3D
4. PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343 1594-602 11096166 10.1056/NEJM200011303432202 1:CAS:528:DC%2BD3cXovVeltLk%3D
5. EW St Clair DM van der Heijde JS Smolen RN Maini JM Bathon P Emery 2004 Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial. Arthritis Rheum 50 3432-43 15529377 10.1002/art.20568 1:CAS:528:DC%2BD2cXhtVOqtrvJ
6. RS Wallis MS Broder JY Wong ME Hanson DO Beenhouwer 2004 Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38 1261-5 15127338 10.1086/383317 1:STN:280:DC%2BD2c3islCksg%3D%3D
7. RS Wallis M Broder J Wong A Lee L Hoq 2005 Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 41 Suppl 3 S194-8 15983899 10.1086/429996 1:CAS:528:DC%2BD2MXotFWktrk%3D
8. KL Winthrop 2006 Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2 602-10 17075599 10.1038/ ncprheum0336 1:CAS:528:DC%2BD28Xht1emtLnO
9. DJ Rychly JT DiPiro 2005 Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 25 1181-92 16164393 10.1592/ phco.2005.25.9.1181 1:CAS:528:DC%2BD2MXhtVGisbvJ
10. MF Doran CS Crowson GR Pond WM O'Fallon SE Gabriel 2002 Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46 2287-93 12355475 10.1002/ art.10524
11. C Vitali S Bombardieri R Jonsson HM Moutsopoulos EL Alexander SE Carsons 2002 Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 554-8 12006334 10.1136/ard.61.6.554 1:STN:280:DC%2BD383pvFyhtA%3D%3D
12. MH Buch H Marzo-Ortega SJ Bingham P Emery 2004 Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: Outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 43 243-4 10.1093/rheumatology/keg454 1:STN:280:DC%2BD2c7gsVamtQ%3D%3D
13. MA Quinn PG Conaghan PJ O'Connor Z Karim A Greenstein A Brown 2005 Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a 12-month-randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 27-35 15641102 10.1002/ art.20712 1:CAS:528:DC%2BD2MXht1KisLY%3D
14. YP Goekoop-Ruiterman JK de Vries-Bouwstra CF Allaart D van Zeben PJ Kerstens JM Hazes 2005 Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 52 3381-90 16258899 10.1002/art.21405 1:CAS:528:DC%2BD2MXht1KrtbfL
15. YP Goekoop-Ruiterman JK de Vries-Bouwstra CF Allaart D van Zeben PJ Kerstens JM Hazes 2007 Comparison of treatment strategies in early rheumatoid arthritis: A randomized trial. Ann Intern Med 146 406-15 17371885
16. SM van der Kooij AE van der Biji CF Allaart YP Goekoop-Ruiterman JK de Vries-Bouwstra AH Gerards 2006 Remission induction in early rheumatoid arthritis (RA) with initial inflixima (IFX) and methotrexate (MTX) therapy: The disease course after IFX discontinuation in the BeSt trial. Arthritis Rheum 54 Suppl S302
17. T Yamada A Nakajima E Inoue E Tanaka M Hara T Tomatsu 2006 Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 65 1661-3 16837491 10.1136/ard.2005.047274 1:STN:280:DC%2BD28jgvFKjtQ%3D%3D
18. SL Brown MH Greene SK Gershon ET Edwards MM Braun 2002 Tumor necrosis factor antagonist therapy and lymphoma development: 26 cases reported to the Food and Drug Administration. Arthritis Rheum 46 3151-8 12483718 10.1002/art.10679 1:CAS:528:DC%2BD3sXjslGisg%3D%3D
19. S Setoguchi DH Solomon ME Weinblatt JN Katz J Avorn RJ Glynn 2006 Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 54 2757-64 16947774 10.1002/ art.22056 1:CAS:528:DC%2BD28XhtFWksLjO
20. E Baecklund A Ekbom P Sparen N Feltelius L Klareskog 1998 Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 317 180-1 9665898 1:STN:280:DyaK1czjt1KltA%3D%3D
21. SS Kassan TL Thomas HM Moutsopoulos R Hoover RP Kimberly DR Budman 1978 Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89 888-92 102228 1:STN:280:CSaD28%2FlvVQ%3D
22. JS Smolen DM Van Der Heijde EW St Clair P Emery JM Bathon E Keystone 2006 Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial. Arthritis Rheum 54 702-10 16508926 10.1002/art.21678 1:CAS:528:DC%2BD28XjtV2ls74%3D
23. JP Utz SJ Swensen MA Gertz 1996 Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med 124 407-13 8554249 1:STN:280:BymC2M7psVA%3D
24. JD Sipe 1994 Amyloidosis. Crit Rev Clin Lab Sci 31 325-54 7888076 10.3109/10408369409084679 1:CAS:528:DyaK2MXktFKmtbg%3D
25. JD Gillmore PN Hawkins 1999 Amyloidosis and the respiratory tract. Thorax 54 444-51 10212113 1:STN:280:DyaK1MzgvFWgsQ%3D%3D
26. P Westermark MD Benson JN Buxbaum AS Cohen B Frangione S Ikeda 2002 Amyloid fibril protein nomenclature - 2002 Amyloid 9 197-200 12408684 1:CAS:528:DC%2BD38XovVGks70%3D 197-200
27. T Miyamoto T Kobayashi M Makiyama S Kitada M Fujishima Y Hagari 1999 Monoclonality of infiltrating plasma cells in primary pulmonary nodular amyloidosis: Detection with polymerase chain reaction. J Clin Pathol 52 464-7 10562817 1:STN:280:DC%2BD3c%2FivVGmtQ%3D%3D
28. Y Hagari M Mihara I Konohana H Ueki O Yamamoto H Koizumi 1998 Nodular localized cutaneous amyloidosis: Further demonstration of monoclonality of infiltrating plasma cells in four additional Japanese patients. Br J Dermatol 138 652-4 9640373 10.1046/j.1365-2133.1998.02179.x 1:STN:280:DyaK1czgsVGmtw%3D%3D
29. RH Laeng HJ Altermatt BW Scheithauer DR Zimmermann 1998 Amyloidomas of the nervous system: A monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Cancer 82 362-74 9445195 10.1002/ (SICI)1097-0142(19980115)82:2<375::AID-CNCR18>3.0.CO;2-W 1:STN:280:DyaK1c7gsF2ksQ%3D%3D
30. FP Quismorio Jr 1996 Pulmonary involvement in primary Sjogren's syndrome. Curr Opin Pulm Med 2 424-8 9363178 10.1097/ 00063198-199609000-00013
31. H Kobayashi R Matsuoka S Kitamura N Tsunoda K Saito 1988 Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis Chest 94 438-40 3396429 10.1378/chest.94.2.438 1:STN:280:BieB1czislM%3D
32. YJ Jeong KS Lee MP Chung J Han MJ Chung KI Kim 2004 Amyloidosis and lymphoproliferative disease in Sjögren's syndrome: Thin-section computed tomography findings and histopathologic comparisons J Comput Assist Tomogr 28 776-81 15538150 10.1097/00004728-200411000-00008